ANI Pharmaceuticals Inc ANIP:NASDAQ

Last Price$37.47NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/12/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$14.88 (2)
Ask (Size)$37.48 (6)
Day Low / HighN/A - N/A
Volume91.7 K

View Biotechnology IndustryPeer Comparison as of 08/12/2022


ANI Pharmaceuticals Inc ( NASDAQ )

Price: $37.47
Change: +2.08 (5.88%)
Volume: 91.7 K
4:00PM ET 8/12/2022

Seres Therapeutics Inc ( NASDAQ )

Price: $5.37
Change: +0.30 (5.92%)
Volume: 553.5 K
4:00PM ET 8/12/2022

Kodiak Sciences Inc ( NASDAQ )

Price: $12.20
Change: +0.43 (3.65%)
Volume: 650.8 K
4:00PM ET 8/12/2022

Cara Therapeutics Inc ( NASDAQ )

Price: $11.51
Change: -0.12 (1.03%)
Volume: 352.1 K
4:00PM ET 8/12/2022

Organogenesis Holdings Inc ( NASDAQ )

Price: $4.72
Change: -0.06 (1.26%)
Volume: 997.9 K
4:00PM ET 8/12/2022

Read more news Recent News

ANI Pharmaceuticals Q2 Adjusted Earnings Fall While Revenue Rises; Reaffirms 2022 Outlook
7:08AM ET 8/08/2022 MT Newswires

ANI Pharmaceuticals (ANIP) on Monday reported Q2 adjusted earnings of $0.13 per diluted share, down from $0.67 a year earlier. Three analysts polled by...

-- Earnings Flash (ANIP) ANI PHARMACEUTICALS Reports Q2 Revenue $73.9M
6:51AM ET 8/08/2022 MT Newswires


-- Earnings Flash (ANIP) ANI PHARMACEUTICALS Posts Q2 EPS $0.13
6:51AM ET 8/08/2022 MT Newswires


ANI Pharmaceuticals Launches Generic Version of Sectral
2:12PM ET 8/03/2022 MT Newswires

ANI Pharmaceuticals (ANIP) said Wednesday it has launched acebutolol hydrochloride capsules, which are the generic version of Sectral. The company said...

Company Profile

Business DescriptionANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN. View company web site for more details
Address210 Main Street West
Baudette, Minnesota 56623
Number of Employees299
Recent SEC Filing08/08/202210-Q
President, Chief Executive Officer & DirectorNikhil Lalwani
Senior VP-Operations & Product DevelopmentJames G. Marken
Chief Financial Officer & Senior VP-FinanceStephen P. Carey
Director & Head-Research & DevelopmentMuthusamy Shanmugam

Company Highlights

Price Open$35.46
Previous Close$35.39
52 Week Range$22.31 - 60.23
Market Capitalization$653.0 M
Shares Outstanding17.4 M
SectorHealth Technology
Next Earnings Announcement11/07/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$3.60
Beta vs. S&P 500N/A
Revenue$201.6 M
Net Profit Margin-27.78%
Return on Equity-23.09%

Analyst Ratings as of 11/01/2021

Consensus RecommendationConsensus Icon
Powered by Factset